Wednesday, April 24, 2024 4/24/2024

Mechanisms underlying hepatic immune cell recruitment in nonalcoholic fatty liver disease

Award Number: R01DK124351
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

PROJECT SUMMARY/ABSTRACT Nonalcoholic fatty liver disease (NAFLD) is a spectrum of progressive conditions ranging from nonalcoholic fatty liver (NAFL) or hepatic steatosis to the more severe nonalcoholic steatohepatitis (NASH) characterized by excessive inflammation and varying degrees of fibrosis. NASH-related cirrhosis is the second leading cause of liver transplantation in the United States and NASH patients face an increased risk of developing hepatocellular carcinoma. The incidence of NASH and NASH-related cirrhosis continues to rise; there, are no FDA-approved therapies as we lack a clear understanding of the cellular and molecular mechanisms driving the progression of NAFL to NASH and the subsequent development of cirrhosis. While there is mounting evidence that inflammation is central to the initiation and progression of NAFLD, the specific immune pathways that drive inflammation in this setting are not well understood. The objective of this proposal is to improve our functional understanding of the mechanisms by which immune cells contribute to NASH-related hepatic inflammation, and to identify the key molecules underlying recruitment of immune cells to the liver. Our published findings and preliminary data have demonstrated that the heterodimeric integrin receptor a4ß7 and its ligand, mucosal addressin cell adhesion molecule-1 (MAdCAM-1), play a pivotal role in NASH-related hepatic inflammation and fibrosis by promoting the recruitment of inflammatory monocytes and CD4 T cells to the liver. These data provide the scientific rationale for our central hypothesis that the a4ß7/MAdCAM-1 axis drives hepatic inflammation and fibrosis in NASH by promoting recruitment of proinflammatory monocytes and CD4 T cells to the liver. We will test this hypothesis in both a mouse model of progressive NAFLD and in human liver tissue from NASH patients according to the following integrated Specific Aims. Aim 1 will investigate the contribution of a4ß7+ monocytes and CD4 T cells in promoting hepatic inflammation in NASH. Aim 2 focuses on the role of hepatic stellate cells in the regulation of immune cell recruitment to the NASH liver. Lastly, Aim 3 investigates the mechanisms regulating the a4ß7/MAdCAM-1 axis in NASH. The results of our investigations will provide comprehensive and mechanistic insights into the inflammatory events crucial to the pathogenesis of NASH, and may lead to the identification of viable therapeutic targets for regulating hepatic inflammation. Given the importance of immune cells in governing metabolic inflammation and the therapeutic potential of targeting immune cells, this proposal addresses significant and clinically relevant issues in NASH.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $423,551 )
2023	2023	UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION	4200 FIFTH AVENUE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	3/7/2023	NON-COMPETING CONTINUATION	$423,551
														Subtotal = $423,551

Issue Date FY: 2022 ( Subtotal = $421,886 )
2022	2022	UNIVERSITY OF PITTSBURGH, THE	4200 5TH AVE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	3/25/2022	NON-COMPETING CONTINUATION	$421,886
														Subtotal = $421,886

Issue Date FY: 2021 ( Subtotal = $416,891 )
2021	2021	UNIVERSITY OF PITTSBURGH, THE	4200 5TH AVE	PITTSBURGH	PA	15260	ALLEGHENY	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	3/15/2021	NEW	$416,891
														Subtotal = $416,891

Grand Total All Awards = $1,262,328

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mechanisms underlying hepatic immune cell recruitment in nonalcoholic fatty liver disease

Award Number: R01DK124351

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer